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Abstract
 
Innate immune mechanisms against 
 
Pneumocystis carinii
 
, a frequent cause of pneumonia in immuno-
compromised individuals, are not well understood. Using both real time polymerase chain reaction
as a measure of organism viability and fluorescent deconvolution microscopy, we show that
 
nonopsonic phagocytosis of 
 
P. carinii
 
 by alveolar macrophages is mediated by the Dectin-1
 
 
 
-glucan receptor and that the subsequent generation of hydrogen peroxide is involved in alveolar
 
macrophage–mediated killing of 
 
P. carinii
 
. The macrophage Dectin-1 
 
 
 
-glucan receptor colo-
calized with the 
 
P. carinii
 
 cyst wall. However, blockage of Dectin-1 with high concentrations of
anti–Dectin-1 antibody inhibited binding and concomitant killing of 
 
P. carinii
 
 by alveolar
macrophages. Furthermore, RAW 264.7 macrophages overexpressing Dectin-1 bound 
 
P. carinii
 
at a higher level than control RAW cells. In the presence of Dectin-1 blockage, killing of
opsonized 
 
P. carinii
 
 could be restored through Fc
 
 
 
RII/III receptors. Opsonized 
 
P. carinii
 
 could
also be efficiently killed in the presence of Fc
 
 
 
RII/III receptor blockage through Dectin-
1–mediated phagocytosis. We further show that Dectin-1 is required for 
 
P. carinii
 
–induced
macrophage inflammatory protein 2 production by alveolar macrophages. Taken together,
these results show that nonopsonic phagocytosis and subsequent killing of 
 
P. carinii
 
 by alveolar
macrophages is dependent upon recognition by the Dectin-1 
 
 
 
-glucan receptor.
Key words: lung • leukocyte • innate • yeast • chemokine
 
Introduction
 
Pneumonia caused by 
 
Pneumocystis carinii
 
 (now 
 
Pneumocystis
jiroveci
 
 in humans) continues to be a predominant cause of
morbidity and mortality in immunocompromised individuals,
especially those infected with HIV (1). Although the advent
of highly active antiretroviral therapy has decreased the over-
all incidence of 
 
P. carinii
 
 pneumonia (2), the mortality rate of
those requiring hospitalization remains high (2). Furthermore,
 
previous 
 
P. carinii
 
 pneumonia significantly predisposes HIV
 
 
 
individuals to bacterial pneumonia (3), currently the most
common cause of pneumonia in this population (4).
Innate host defenses, mediated primarily by alveolar
macrophages, against 
 
P. carinii
 
 have been studied exten-
sively. It is widely reported that phagocytosis by alveolar
macrophages is the predominant mechanism of 
 
P. carinii
 
clearance from the lungs (5–7). This clearance is thought to
involve the recognition of mannose-containing residues on
the major surface glycoprotein A, gpA, of 
 
P. carinii
 
 by the
macrophage mannose receptor (MR; 8). 
 
 
 
-glucans, a major
component of the 
 
P. carinii
 
 cell wall, have also been shown
to elicit critical proinflammatory cytokines such as TNF-
 
 
 
and chemokines such as macrophage inflammatory protein
(MIP)-2 (9–11) from alveolar macrophages. However, the
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mechanisms by which macrophages phagocytose and kill 
 
P.
carinii
 
 are not completely understood. It is hypothesized
that upon phagocytosis, the oxidative burst by macro-
phages, primarily the generation of hydrogen peroxide and
superoxide, has a direct cytotoxic effect on 
 
P. carinii
 
 (12–
14). Indeed, studies have shown impaired hydrogen perox-
ide and superoxide production by alveolar macrophages
from HIV
 
  
 
individuals with 
 
 
 
200 CD4
 
  
 
T cells/mm
 
3 
 
with
and without 
 
P. carinii
 
 infection (15).
A major limitation in investigations of 
 
P. carinii
 
 is the
lack of the ability of the organism to be cultured in vitro
(16). Due to this limitation, traditional in vitro assays using
radiometric labeling of 
 
P. carinii
 
 have not provided robust
measurements of organism viability (6, 17). In this study,
using quantitative real time PCR for 
 
P. carinii
 
 ribosomal
RNA integrity, which correlates with organism viability
(18, 19), we demonstrate that in vitro killing of nonop-
sonized 
 
P. carinii
 
 by alveolar macrophages involves recogni-
tion by the newly described Dectin-1 
 
 
 
-glucan receptor, a
small, type II transmembrane protein that functions as the
predominant 
 
 
 
-glucan pattern recognition receptor on
macrophages (20, 21). Moreover, recognition by Dectin-1
mediates release of the proinflammatory CXC chemokine
MIP-2 by alveolar macrophages.
 
Materials and Methods
 
Mice.
 
Male C57BL/6 mice, 6–8 wk of age, were purchased
from the National Cancer Institute, National Institutes of Health.
MR-deficient (MR
 
 
 
/
 
 
 
) mice were generated on the 129SvJ 
 
 
 
C57BL/6 background and were backcrossed to the C57BL/6
strain for seven generations (22). All animals were housed in a
specific pathogen-free facility and handled according to institu-
tionally recommended guidelines.
 
Peritoneal and Alveolar Macrophage Isolation.
 
To isolate perito-
neal macrophages, male C57BL/6 mice were administered 3%
sterile thioglycollate intraperitoneally and allowed to rest for 5–7 d.
Thereafter, animals were killed and a peritoneal lavage was per-
formed using 10 ml RPMI 1640 (Invitrogen). The lavage fluid
was centrifuged at 300 
 
g 
 
for 10 min and the subsequent cell pellets
were enumerated using a hemacytometer. For alveolar macrophage
isolation, male C57BL/6 or MR
 
 
 
/
 
  
 
mice were anesthetized with
intraperitoneal pentobarbital and killed by exsanguination. There-
after, lungs were lavaged through an intratracheal catheter with
prewarmed (37
 
 
 
C) calcium and magnesium-free PBS supple-
mented with 0.6 mM EDTA. A total of 10 ml was used in each
mouse in 0.5-ml increments with a 30-s dwell time. The lavage
fluids were pooled and centrifuged at 300 
 
g
 
 for 10 min, and the
cells were collected for the coculture assay. To ensure that each
cell preparation was enriched for macrophages, 25,000 cells were
cytospun onto slides and stained with hematoxylin and eosin.
Cell preparations were generally 
 
 
 
98% enriched for peritoneal or
alveolar macrophages.
 
P. carinii f. sp. muris Isolate.
 
A preparation of 
 
P. carinii
 
 was
prepared as previously described (23, 24). In brief, CD40 ligand
knockout mice previously inoculated with 
 
P. carinii
 
 were injected
with a lethal dose of pentobarbital, and the lungs were aseptically
removed and frozen for 30 min at 
 
 
 
70
 
 
 
C in 1 ml PBS. Frozen
lungs were thereafter homogenized in 10 ml PBS (Model 80
Stomacher; Tekmar Instruments), filtered through sterile gauze,
 
and pelleted at 500 
 
g 
 
for 10 min at 4
 
 
 
C. The pellet was resus-
pended in PBS and the number of 
 
P. carinii
 
 cysts were enumer-
ated microscopically using a modified Giemsa stain (Diff-Quik;
Baxter). The preparation was adjusted to 2 
 
  
 
10
 
6 
 
cysts/ml and 50
 
 
 
l aliquots were placed into tubes containing 200 
 
 
 
l 90% fetal
bovine serum supplemented with 10% dimethylsulfoxide and
stored at 
 
 
 
80
 
 
 
C. Using this storage method, stable 
 
P. carinii
 
 via-
bility, as determined by quantitative real time PCR (18), can be
maintained for 
 
 
 
1 yr.
 
P. carinii Viability Assay.
 
Macrophages (10
 
6
 
/ml) in a volume
of 100 
 
 
 
l were cocultured with 
 
P. carinii
 
 (10
 
4 
 
cysts/ml, 100 
 
 
 
l)
for 16 h at 37
 
 
 
C, 5% CO
 
2
 
. Controls include 
 
P. carinii
 
 incubated
with medium alone. The contents of each well were collected
and pelleted at 800 
 
g 
 
for 5 min. The supernatants were discarded
and total RNA was isolated from the cell pellets using TRI-
ZOL™ reagent (Invitrogen). Viability of 
 
P. carinii
 
 was analyzed
through real time PCR measurement of rRNA copy number and
quantified by using a standard curve of known copy number of 
 
P.
carinii
 
 rRNA as previously described (18). This methodology de-
tects viable 
 
P. carinii
 
 organisms as evidenced by the absence of de-
tectable 
 
P. carinii
 
 rRNA in samples subjected to heat inactivation
or exposure to trimethoprim/suflamethoxazole. Percent killing
was defined as: 1 
 
  
 
rRNA copy number from wells containing
macrophages 
 
  
 
P. carinii
 
 rRNA copy number from wells con-
taining 
 
P. carinii
 
 alone 
 
  
 
100.
 
Analysis of Phagocytosis and Oxidative Killing Mechanisms.
 
In
experiments to determine whether phagocytosis was critical for
macrophage killing of 
 
P. carinii
 
, macrophages were pretreated
with 10 
 
 
 
M cytochalasin D for 30 min at 37
 
 
 
C (Sigma-Aldrich).
Thereafter, the macrophages were washed twice and cocultured
with 
 
P. carinii
 
. To address oxidative killing mechanisms, macro-
phages and 
 
P. carinii
 
 were cocultured in the presence or absence
of 5,000 U/ml catalase, 1 mM N
 
 
 
-nitro-L-arginine methyl ester
(both from Sigma-Aldrich), or 100 
 
 
 
M manganese(III)tetrakis(1-
methyl-4-pyridyl)porphyrin pentachloride (MnTMPyP; Calbio-
chem). There was no effect of any reagent on macrophage viability.
Controls included 
 
P. carinii cultured in the presence or absence of
each reagent.
 -Glucan and MR Carbohydrate Inhibition Experiments. In ex-
periments to determine the effects of  -glucan and MR blockage
on the killing of P. carinii, macrophages were preincubated with
medium alone or 100–600  g/ml glucan or mannan for 30 min
at 37 C (all from Sigma-Aldrich), and P. carinii was added thereaf-
ter. Controls included P. carinii cultured in the presence or ab-
sence of glucan or mannan.
FITC Labeling of P. carinii. P. carinii was labeled with FITC as
previously described (25). In brief, 5-ml suspensions of P. carinii
(4   105 cysts/ml) were incubated with 0.1 mg/ml FITC in PBS
(Sigma-Aldrich) for 30 min at 37 C. Thereafter, the suspension
was washed three times for 10 min at 1,300 g. The final pellet was
resuspended in 1 ml medium and a small aliquot was viewed un-
der fluorescent microscopy for confirmation of FITC labeling.
Both cyst and trophozoite forms were labeled and viability was
not affected.
Analysis of Dectin-1. Initial experiments determined that alve-
olar macrophages expressed high levels of Dectin-1. In experi-
ments to determine the effects of blocking the Dectin-1  -glucan
receptor on macrophage-mediated killing, macrophages were
preincubated with 2.0  g/ml of the monoclonal antibody 2A11
for 30 min at 37 C, a rat anti–mouse Dectin-1 IgG2b antibody
(20), and thereafter cocultured with P. carinii. Controls included
macrophages cultured with an irrelevant IgG2b antibody and P.
carinii cultured in the presence or absence of either antibody.Steele et al. 1679
In Vitro Binding Assay. RAW 264.7 cells (American Type
Culture Collection) overexpressing Dectin-1 (RAW-Dectin) or
control cells (RAW-FB) were cultured as previously described
(26). These cells or 1–2   105 C57BL/6 primary alveolar macro-
phages in a volume of 200  l were adhered to sterile 13-mm
round glass coverslips for 2–3 h at 37 C (24). The coverslips were
washed to remove nonadherent cells and 1–2   105 FITC-conju-
gated P. carinii cysts in a volume of 200  l was added to each cov-
erslip for 1 h at 37 C. Thereafter, the coverslips were washed to
remove unbound/unphagocytosed FITC-P. carinii. In specific
experiments, adherent macrophages were preincubated with low
(0.1  g/ml, which does not inhibit binding and killing) or high
(2.0  g/ml, which does inhibit binding and killing) concentra-
tions of the anti–Dectin-1 monoclonal antibody 2A11 before the
addition of FITC-P. carinii.
Analysis of P. carinii Cyst Binding by Fluorescent Deconvolution Mi-
croscopy. Adherent alveolar macrophages were incubated with
Alexa Fluor 568–conjugated goat anti–rat IgG2b (Molecular
Probes) for detection of the anti–Dectin-1 monoclonal antibody
2A11 for 30 min at room temperature. Thereafter, adherent mac-
rophages were fixed with 4% formaldehyde and counterstained
with 0.4  g/ml DAPI (Molecular Probes) nucleic acid stain for 2
min at room temperature followed by application of Prolong™
(Molecular Probes) mounting media. The coverslips were ana-
lyzed on a Leica DMRXA automated upright epifluorescent mi-
croscope (Leica) equipped with a Sensicam QE CCD digital cam-
era (Cooke Corporation) and filter sets for FITC (exciter HQ480/
20, dichroic Q495LP, and emitter HQ510/20m), Alexa 568
(exciter 560/55x, dichroic Q595LP, and emitter HQ645/75m),
and DAPI (exciter 360/40x, dichroic 400DCLP, and emitter
GG420LP). Slidebook™ deconvolution software (Intelligent Im-
aging Innovations) mathematical algorithms were applied to isolate
and calculate macrophage surface area binding over 20 fields at
 400. Data was expressed as the amount of alveolar macrophage
surface area interacting with P. carinii (surface area in  m2).
In specific experiments using RAW 264.7 macrophages, fluo-
rescence superimposition over Nomarski optics (differential inter-
ference contrast microscopy) was used to enumerate P. carinii
binding to macrophages. Images were captured and deconvolved
using Slidebook™ software and enumerated. Data was expressed
as percent of cells with P. carinii bound.
In Vitro Phagocytosis Assay. For Alexa Fluor labeling of P. car-
inii, P. carinii was resuspended in PBS at 108 organisms/ml and 50
mM sodium carbonate was added to increase the pH to 8.5. The
organisms were then fluorescently labeled by adding Alexa Fluor
488 succinimidyl ester (Molecular Probes) at a final concentration
of 0.4 mg/ml. The P. carinii preparation was mixed and rocked at
room temperature for 30 min, and then washed three times in
cold PBS. The fluorescently labeled particles were recounted and
resuspended at 108 organisms/ml and placed at 4 C until use in
the phagocytosis assay.
Alveolar macrophages were isolated from C57BL/6 or MR / 
mice as described above. 3   105 macrophages in a volume of
100  l were aliquoted into polypropylene tubes and incubated
with isotype control antibody or 2.0  g/ml of the anti–Dectin-1
monoclonal antibody 2A11 for 30 min at 37 C. Thereafter, 100
 l Alexa fluorescently labeled P. carinii was added at a ratio of five
P. carinii organisms to one macrophage. This coculture was incu-
bated at 37 C for 80–90 min with occasional mixing. The macro-
phages were washed once, resuspended in 200  l PBS. The red
fluorescent carbocyanine lipid probe DiI (for macrophage label-
ing; Molecular Probes) was then added at a final concentration of
50  g/ml. After 10 min at room temperature, the macrophages
were washed, resuspended in 200  l cold PBS, and placed on ice
until analysis with confocal laser scanning microscopy. For micro-
scopic examination, aliquots of the cells were placed individually
into a glass-bottom 96-well plate and analyzed with a Zeiss LSM
510 Scanning Microscope. 15 fields were analyzed in each well,
with 20 optical sections (each 0.8–1.0- m thick) taken through
the depth of the cells. Alexa Fluor–labeled P. carinii were deter-
mined to be bound to the surface of the macrophages or internal-
ized by examining their position in relation to the DiI-labeled
macrophage membranes throughout the entire depth of individ-
ual cells. Data was expressed as the mean number of internalized
P. carinii organisms per alveolar macrophage.
Analysis of MIP-2 Production. Alveolar macrophages or
RAW-Dectin and RAW-FB cells (2   105) were cocultured
with P. carinii at macrophage to total P. carinii organism ratios of
1:10 and 1:100 in the presence of rat IgG or 2A11 for 16 h in a
96-well plate at 37 C, 5% CO2. Controls included alveolar mac-
rophage cultured in medium alone. Thereafter, the contents of
each well were collected and the supernatants were analyzed for
MIP-2 concentrations using a commercially available ELISA kit
(R&D Systems) according to the manufacturer’s instructions.
Statistical Analysis. Data were analyzed using StatView statis-
tical software (Brainpower Inc.). Comparisons between groups
were made with analyses of variance and appropriate ad hoc test-
ing. The Mann-Whitney U test or the Wilcoxon paired sample
test was used to make ordinal comparisons. Significance was ac-
cepted at P   0.05.
Figure 1. Reduction in P. carinii viability during coculture with alveolar
and peritoneal macrophages. Alveolar or peritoneal macrophages were
isolated from 6–8-wk-old, male C57BL/6 mice and cocultured overnight
with a constant number of P. carinii organisms. Controls included P. carinii
cultured in the absence of macrophages. Thereafter, RNA was isolated
from the contents of each well and quantitative real time PCR for P. carinii
rRNA copy number was performed. Cumulative results from six separate
experiments for P. carinii rRNA copy number (A) and percent killing (B)
are shown. *, significant differences between alveolar macrophages or peri-
toneal macrophages compared with P. carinii (PC) alone (P   0.0013 and
0.0017 for alveolar and peritoneal macrophages, respectively; A). Data are
expressed as mean copy number (A) or mean percent killing (B)   SEM.Macrophage Killing of Pneumocystis carinii 1680
Results
Reduction in P. carinii Viability During Coculture with Alveo-
lar or Peritoneal Macrophages. To better understand inter-
actions and the recognition of P. carinii by tissue macro-
phages, we used both thioglycollate-elicited peritoneal
macrophages as a control for an elicited macrophage popu-
lation and alveolar macrophages as a source of resident tis-
sue macrophages. Various ratios of alveolar and peritoneal
macrophages were cocultured with a constant number of
P. carinii organisms in a 96-well tissue culture plate. P. car-
inii was cultured alone as a control for 100% viability.
Thereafter, the contents of each well were collected,
RNA was isolated, and real time quantitative PCR for P.
carinii rRNA was performed. The ED50 of both popula-
tions of macrophages to mediate a 50% reduction in P. car-
inii rRNA integrity, a measure of organism viability, was
similar at a ratio of 100 macrophages to 1 P. carinii cyst
(Fig. 1, A and B), which correlates with a 1:1 macrophage
to total P. carinii (cysts plus trophozoites) in our P. carinii
preparations (27).
Alveolar Macrophage–mediated Killing of P. carinii Requires
Phagocytosis and Involves Generation of Reactive Oxygen Spe-
cies. To determine putative mechanism(s) by which alve-
olar macrophages killed P. carinii, we investigated the role
of phagocytosis and the subsequent release of reactive oxy-
gen/nitrogen species. After pretreatment with cytochalasin
D, alveolar macrophages lost their ability to phagocytose
the organism, and thus their ability to reduce P. carinii
rRNA copy number in vitro compared with those pre-
treated with medium alone (Fig. 2 A). To confirm that in-
ternalization of P. carinii was essential for the detected re-
duction in viability, we performed an in vitro binding/
phagocytosis assay using FITC-conjugated P. carinii cysts
and used fluorescent deconvolution microscopy to deter-
mine whether untreated or cytochalasin D–treated alveolar
macrophages phagocytosed P. carinii. The representative
micrograph in Fig. 2 B shows the engulfment of the cyst
form of P. carinii by an untreated alveolar macrophage. P.
carinii organisms were not observed to be associated or in-
ternalized in cytochalasin D–treated alveolar macrophages
(unpublished data).
To address the role of superoxide in P. carinii killing by
alveolar macrophages, we cocultured macrophages and P.
carinii in the presence of MnTMPyP, a cell-permeable su-
peroxide dismutase mimetic (28). Although superoxide has
been implicated in alveolar macrophage function against P.
carinii (13), alveolar macrophage–mediated killing of P. cari-
nii remained intact in the presence of superoxide dismuta-
tion (Fig. 2 C). In contrast, decomposition of hydrogen
peroxide by catalase significantly attenuated alveolar mac-
rophage–mediated killing of P. carinii (Fig. 2 C). Additional
studies showed that P. carinii incubated overnight in the
presence of physiologic concentrations of hydrogen perox-
ide (29) had a reduction in viability (26.4   1.1% and 42.8  
2.1% killing for 10 and 100  M H2O2, respectively). Inhi-
bition of nitric oxide synthesis had no effect on alveolar
macrophage–mediated killing of P. carinii (Fig. 2 C).
Figure 2. Alveolar macrophage–mediated killing of P. carinii requires
phagocytosis and generation of reactive oxygen species. Alveolar macro-
phages were isolated from 6–8-wk-old, male C57BL/6 mice and were
pretreated with 10  M cytochalasin D for 30 min at 37 C, washed, and
cocultured overnight with P. carinii at a macrophage to P. carinii cyst ratio
of 100:1 (A). Controls included P. carinii cultured in the absence of macro-
phages. In B, an in vitro phagocytosis assay was performed with alveolar
macrophages and FITC-labeled P. carinii. A representative micrograph
( 630) shows phagocytosis of P. carinii cyst and trophozoite forms (red
arrows). Blue indicates DAPI-stained nucleic acid, green indicates FITC
on the P. carinii surface, and red indicates phalloidin staining for F-actin.
In C, alveolar macrophages were cocultured overnight with P. carinii at a
macrophage to PC cyst ratio of 100:1 in the presence of 100  M MnT-
MPyP, 5,000 U/ml catalase, 1 mM N -nitro-L-arginine methyl ester
(L-NAME), or 100 and 10  M hydrogen peroxide. Controls include P.
carinii cultured in the absence of macrophages but in the presence of each
compound separately. Thereafter, RNA was isolated from the contents of
each well and quantitative real time PCR for P. carinii rRNA copy
number was performed. Cumulative results from four separate experi-
ments (A and C) are shown. *, significant differences between untreated
and cytochalasin D–treated alveolar macrophages (P   0.003; A) and
untreated and catalase-treated alveolar macrophages (P   0.005; C). Data
are expressed as mean percent killing   SEM.Steele et al. 1681
were performed to determine whether Dectin-1 was ex-
pressed on the surface of alveolar macrophages. Using fluo-
rescent deconvolution microscopy and a novel anti–Dec-
tin-1 monoclonal antibody (2A11; reference 20), we show
that alveolar macrophages expressed significant levels of the
Dectin-1   -glucan receptor (Fig. 4 A). Previous studies
have shown that high concentrations of 2A11 (100  g/ml)
can inhibit the binding of zymosan to macrophages (20).
Using 50-fold less concentrations of 2A11 (2.0  g/ml) re-
sulted in a significant abrogation of alveolar macrophage–
mediated killing of P. carinii (Fig. 4 B).
Next, we sought to confirm that the Dectin-1  -glucan
receptor was required for recognition and binding of P. car-
inii by using an in vitro binding assay containing FITC-
labeled P. carinii cysts that used fluorescent deconvolution
microscopy for visualization and quantification of P. carinii
binding to alveolar macrophages. Using a low concentra-
tion of 2A11 (0.1  g/ml), which did not block P. carinii
killing by alveolar macrophages (unpublished data) but effi-
ciently labeled Dectin-1 on alveolar macrophages, did not
affect the ability of alveolar macrophages to bind P. carinii
(Fig. 4 C, left). Similar data were observed with unstained
cells (unpublished data). Using Slidebook™ analysis soft-
ware, we calculated the amount of P. carinii binding to
alveolar macrophages pretreated with low and high con-
centrations of 2A11. As shown in Fig. 4 D, alveolar macro-
phages pretreated with 0.1  g/ml 2A11 had a higher
surface area bound by P. carinii compared with those pre-
treated with 2.0  g/ml. We also used Slidebook™ analysis
software to perform pseudocolor rendering analysis to de-
termine whether the Dectin-1  -glucan receptor colocal-
ized with the P. carinii cell wall. The high powered micro-
graph illustrated in Fig. 4 E shows significant colocalization
of Dectin-1 with the cell wall P. carinii (green/yellow area
between two gray nuclei; left, alveolar macrophage; right,
P. carinii cyst). In contrast, using concentrations of 2A11,
which blocked alveolar macrophage–mediated killing of P.
carinii (2.0  g/ml; Fig. 4 B), completely abrogated binding
and internalization of P. carinii by alveolar macrophages
(Fig. 4 C, right, and D).
Internalization of P. carinii by Alveolar Macrophages from
Macrophage MR-deficient (MR   ) Mice. As previously
stated, the macrophage MR is thought to mediate initial
recognition and ultimately clearance of P. carinii. To deter-
mine the role of the MR in alveolar macrophage–mediated
recognition of P. carinii, we performed an in vitro phagocy-
tosis assay using Alexa Fluor–conjugated P. carinii cocultured
with alveolar macrophages isolated from MR /  or wild-
type control mice. Results presented in Fig. 5 show that al-
veolar macrophages isolated from MR /  mice can internal-
ize P. carinii at levels equal to that of alveolar macrophages
isolated from wild-type control mice (solid bars). More im-
portantly, when alveolar macrophages from both MR / 
and wild-type strains were pretreated with 2.0  g/ml 2A11,
a significant reduction in P. carinii internalization was ob-
served (gray bars). Analysis of alveolar macrophage Dectin-1
expression by flow cytometry showed no differences be-
tween MR /  and wild-type mice (unpublished data).
Effects of MR and  -Glucan Receptor Blockage on Alveolar
Macrophage–mediated Killing of P. carinii. Macrophages ex-
press multiple molecular recognition receptors that func-
tion in the nonopsonic uptake of pathogenic organisms and
in the activation of inflammatory responses (30). Previous
studies using rat-derived P. carinii cocultured with human
macrophages support a role for the macrophage MR as a
critical molecular recognition receptor required for the up-
take of P. carinii by alveolar macrophages (24). In addition,
 -glucan receptors have been reported to be critical in the
generation of macrophage proinflammatory responses in
response to P. carinii cell wall  -glucans (11). However, the
role of  -glucan and MRs in the specific killing of P. carinii
has not been directly determined. The results illustrated in
Fig. 3 show that competitive carbohydrate blockage of the
macrophage MR with Saccharomyces cerevisiae–derived man-
nan did not reduce the ability of alveolar macrophages to
kill P. carinii in vitro. In contrast, blockage of  -glucan re-
ceptors by preincubation of alveolar macrophages with glu-
can from S. cerevisiae results in a significant decrease in alve-
olar macrophage–mediated killing of P. carinii.
The Role of the Dectin-1  -Glucan Receptor in Pattern Rec-
ognition and Alveolar Macrophage–mediated Killing of P. carinii.
Due to the observation that carbohydrate blockage of
 -glucan receptors, but not the macrophage MR, abrogated
killing of P. carinii by alveolar macrophages, we sought to
further characterize the role of  -glucan receptors in the
killing of P. carinii. Recently, the macrophage  -glucan re-
ceptor that recognizes zymosan, S. cerevisiae, and Candida
albicans was identified as Dectin-1 (20, 26). We questioned
whether Dectin-1 was responsible for nonopsonic alveolar
macrophage–mediated killing of P. carinii. Initial studies
Figure 3. Effects of mannose and  -glucan receptor blockage on alveolar
macrophage–mediated killing of P. carinii. Alveolar macrophages were
isolated from 6–8-wk-old, male C57BL/6 mice and were pretreated with
100–600  g/ml mannan or glucan for 30 min and thereafter added to P.
carinii overnight at a final macrophage to P. carinii cyst ratio of 100:1.
Controls include P. carinii cultured in the absence of macrophages but in
the presence of mannan or glucan. Thereafter, RNA was isolated from
the contents of each well and quantitative real time PCR for P. carinii
rRNA copy number was performed. Cumulative results from four separate
experiments are shown. *, significant differences between untreated and
glucan-treated alveolar macrophages (P   0.008). Data are expressed as
mean percent killing   SEM.Macrophage Killing of Pneumocystis carinii 1682
MIP-2 Production by Alveolar Macrophages in Response to P.
carinii Is Mediated by Dectin-1. As mentioned previously,
purified  -glucan from the cyst cell wall of P. carinii elicits
MIP-2 production by alveolar macrophages (10). However,
it remains unclear whether  -glucan recognition of whole
organisms is required for MIP-2 production. To this end,
we pretreated alveolar macrophages with 2A11 or an iso-
type control antibody and thereafter cocultured them with
P. carinii at a macrophage to total P. carinii (cysts plus tro-
phozoites) ratio of 1:10 and 1:100. After 16 h, MIP-2 levels
in coculture supernatants were quantified. As shown in Fig.
6, Dectin-1 blockage significantly reduced MIP-2 produc-
tion by alveolar macrophages in response to P. carinii.
Binding of P. carinii and MIP-2 Production by RAW 264.7
Macrophages Overexpressing Dectin-1. RAW-264.7 cells, a
murine macrophage cell line, express low endogenous lev-
Figure 4. The role of the Dectin-1  -glucan receptor in alveolar
macrophage–mediated killing of P. carinii. Alveolar macrophages were iso-
lated from 6–8-wk-old, male C57BL/6 mice and were adhered to glass
coverslips. Thereafter, alveolar macrophages were stained with rat IgG
(left) or the anti–Dectin-1 antibody 2A11 (right) and imaged using fluo-
rescent deconvolution microscopy. Blue indicates DAPI-stained nucleic
acid and red indicates positive Dectin-1 staining (A;  400). In B, alveolar
macrophages were pretreated with 2  g/ml rat IgG or 2A11 for 30 min at
37 C and thereafter cocultured with P. carinii at a macrophage to P. carinii
cyst ratio of 100:1. Thereafter, RNA was isolated from the contents of each
well and quantitative real time PCR for P. carinii rRNA copy number was
performed. *, significant differences between macrophages incubated in rat
IgG or 2A11 (P   0.0001). Data are expressed as mean percent killing  
SEM. In C, an in vitro binding assay was performed with alveolar macro-
phages prelabeled with low (0.1  g/ml; left) and high (2.0  g/ml; right)
concentrations of 2A11 and FITC-labeled P. carinii. Blue indicates DAPI-
stained nucleic acid, green indicates FITC on the P. carinii surface, and red
indicates Dectin-1 ( 200). In D, Slidebook™ analysis software algorithms
were used to calculate macrophage surface area that was bound with P. carinii between alveolar macrophages pretreated with low (0.1  g/ml; C, left) and
high (2.0  g/ml; C, right) concentrations of 2A11. In E, pseudocolor rendering analysis was performed by Slidebook™ analysis software to determine
colocalization of Dectin-1 and the P. carinii cell wall (green/yellow area between two gray nuclei; left, alveolar macrophage; right, P. carinii cyst;  630).Steele et al. 1683
els of Dectin-1 (26). To confirm by additional means that
Dectin-1 was indeed the receptor required for recognition
and binding of P. carinii, we used RAW 264.7 macro-
phages transduced with a retrovirus encoding the mu-
rine Dectin-1 cDNA (RAW-Dectin cells; reference 26).
Thereafter, we performed an in vitro binding assay using
FITC-conjugated P. carinii and quantified the level of P.
carinii binding. As shown in the micrographs in Fig. 7 A,
Figure 6. MIP-2 production by alveolar macrophages in response to P.
carinii is mediated by Dectin-1. Alveolar macrophages were isolated from
6–8-wk-old, male C57BL/6 mice and cocultured for 16 h in the presence
of rat IgG or 2A11 with P. carinii at macrophage to total P. carinii organism
ratios of 1:10 and 1:100. Controls included alveolar macrophages cultured
in medium alone. Thereafter, MIP-2 concentrations in coculture super-
natants were determined by ELISA. Cumulative results from four separate
experiments are shown. *, significant differences between cocultures of rat
IgG and 2A11 (P   0.05 and P   0.011 for 1:10 and 1:100, respectively).
Data are expressed as mean MIP-2 pg/ml   SEM.
Figure 5. Internalization of P. carinii by alveolar macrophages collected
from macrophage MR-deficient (MR   ) mice. Alveolar macrophages
were isolated from 6–8-wk-old, male C57BL/6 or MR /  mice and pre-
treated with 2.0  g/ml 2A11 (gray bars) or isotype control antibody
(solid bars). Alexa Fluor 488 succinimidyl ester–labeled P. carinii cysts and
trophozoites were added at a macrophage to P. carinii ratio of 1:5 in an in
vitro phagocytosis assay. Thereafter, aliquots of macrophage/P. carinii co-
cultures were subjected to confocal microscopy for determination of P.
carinii internalization. *, significant differences between cocultures of isotype
and 2A11 (P   0.05). Data are expressed as the mean number of internalized
P. carinii organisms per alveolar macrophage.
Figure 7. P. carinii binding
and MIP-2 production by RAW
264.7 macrophages overexpressing
Dectin-1. In A, an in vitro binding
assay was performed with
RAW-FB or RAW-Dectin
macrophages prelabeled with an
isotype control antibody or 2.0
 g/ml 2A11 and FITC-labeled
P. carinii. Slidebook™ analysis
software was used to capture,
deconvolve, and superimpose
FITC-P. carinii images with
Nomarski macrophage images.
In B, numbers of macrophages
bound with P. carinii were enu-
merated using Slidebook™
software. In C, RAW-FB or
RAW-Dectin macrophages were
cocultured for 16 h in the presence
of rat IgG or 2A11 with P. carinii
at a macrophage to total P. carinii
organism ratio of 1:100. Controls
included macrophages cultured
in medium alone. Thereafter,
MIP-2 concentrations in coculture
supernatants were determined by
ELISA. Cumulative results from
three separate experiments are
shown. *, significant differences
between cocultures of rat IgG
and 2A11 (P   0.05). Data are
expressed as mean MIP-2 pg/
ml   SEM.Macrophage Killing of Pneumocystis carinii 1684
there was little to no binding or association of P. carinii
cysts with RAW-FB macrophages transduced with a con-
trol plasmid (Fig. 7 A, left), whereas RAW-Dectin macro-
phages overexpressing Dectin-1 were capable of binding P.
carinii (Fig. 7 A, middle). Furthermore, when macrophages
overexpressing Dectin-1 were pretreated with 2.0  g/ml
2A11, a significant reduction in binding of P. carinii was
observed (Fig. 7 A, right). Quantitative data of the micro-
scopic analysis is presented in Fig. 7 B.
We also further confirmed that MIP-2 production in
response to P. carinii was associated with Dectin-1 recog-
nition. As illustrated in Fig. 7 C, RAW-Dectin macro-
phages overexpressing Dectin-1 produced significantly
higher levels of MIP-2 than RAW-FB control macro-
phages. Furthermore, pretreatment with 2.0  g/ml 2A11
abrogated MIP-2 production by Dectin-1 overexpressing
RAW macrophages.
Nonopsonic Dectin-1–mediated Phagocytosis Can be Cir-
cumvented by Fc RII/III-mediated Phagocytosis. Antibody-
mediated immunity plays a significant role in protection
against P. carinii (31–33). Because Dectin-1 is required for
nonopsonic phagocytosis of P. carinii, we questioned
whether Dectin-1 was required for opsonic phagocytosis.
The addition of anti–P. carinii IgG-containing sera, which
we have previously shown to be protective in adoptive
transfer experiments (18), to the macrophage/P. carinii co-
culture resulted in a significant enhancement in alveolar
macrophage–mediated P. carinii killing (Fig. 8 A). Comple-
ment was not a factor contributing to the enhanced killing
of P. carinii as heat inactivation of immune sera at 56 C for
30 min had no effect on the enhanced killing (74 and 84%
for immune and immune heat inactivated, respectively).
Next, we questioned whether blockage of nonopsonic
Dectin-1–mediated phagocytosis had an effect on opsonic
phagocytosis. To this end, we preincubated alveolar mac-
rophages with 2A11 and thereafter added anti–P. carinii
IgG-containing sera in conjunction with P. carinii. Op-
sonized P. carinii were efficiently killed by alveolar macro-
phages, despite the macrophage’s inability to recognize P.
carinii through the Dectin-1  -glucan receptor (Fig. 8 A).
To investigate whether this killing was mediated through
Fc RII/III receptors, alveolar macrophages were pre-
treated with both 2A11 and anti-CD16/CD32 antibodies
followed by the addition of anti–P. carinii IgG and P. carinii.
Blockage of both Fc RII/III receptors and Dectin-1 com-
pletely abrogated the killing of opsonized P. carinii (Fig. 8
B). Interestingly, blockage of CD16/CD32 had no effect
on alveolar macrophage–mediated killing of opsonized P.
carinii (Fig. 8 B), suggesting intact Dectin-1–mediated rec-
ognition of opsonized P. carinii.
Discussion
Although cellular interactions with P. carinii are well re-
ported in the literature, significant limitations in the analysis
of P. carinii in vitro exist and therefore need to be taken into
account when evaluating results. First and foremost, P. cari-
nii cannot be cultured in vitro (16). To date, many experi-
mental designs have used methods to radiolabel P. carinii,
which can take up to 24 h before the organism is sufficiently
labeled (6). Furthermore, additional protocols that use the
incorporation of a radioactive compound (17) are based on
the ability of an organism to proliferate in vitro, which is
clearly not the case when dealing with P. carinii. Another
peculiar characteristic of P. carinii is its species specificity. It
has been reported that isolates of P. carinii originally ob-
tained from a human specimen will in general not be patho-
genic to rodents and vice versa (16, 34). However, studies
to date that have often characterized innate recognition of
P. carinii have largely relied on these nonsyngeneic systems
whereby P. carinii from one species is cocultured with cells
from another species (7, 15, 35, 36), which may lead to ab-
errant results. Taken together, there exists a precedent
whereby a better coculture system can be used.
Figure 8. The effects of Dectin-1 blockage in the presence of Fc RII/
III-mediated phagocytosis. Alveolar macrophages were isolated from 6–8-
wk-old, male C57BL/6 mice and added to P. carinii in the presence of
nonopsonizing or opsonizing sera (diluted 1:100; A), pretreated with 2
 g/ml 2A11 for 30 min at 37 C with or without opsonizing sera (A), or
pretreated with 2  g/ml 2A11 and anti-CD16/CD32 (Fc) for 30 min at
37 C with and without opsonizing sera (B), and added to P. carinii over-
night for a final macrophage to P. carinii cyst ratio of 100:1 (A). Controls
included P. carinii cultured without macrophages in the presence of non-
opsonizing or opsonizing sera alone or containing the specific antibody.
Thereafter, RNA was isolated from the contents of each well and quantitative
real time PCR for P. carinii rRNA copy number was performed. Cumulative
results from four separate experiments are shown. In A: *, significant differ-
ences between nonopsonizing versus opsonizing sera (P   0.0002); #, signif-
icant differences between nonopsonizing sera and 2A11 (P   0.0001);
**, significant differences between 2A11 and opsonizing sera plus 2A11
(P   0.0005). In B: *, significant differences between nonopsonizing
versus opsonizing sera (P   0.007); #, significant differences between
nonopsonizing sera and 2A11 (P   0.0001); **, significant differences
between 2A11 and opsonizing sera plus 2A11 plus Fc Block (Fc; P  
0.0001). Data are expressed as mean percent killing   SEM.Steele et al. 1685
Here we report the use of a syngeneic in vitro coculture
system that uses murine alveolar macrophages cocultured
with murine P. carinii that quantifies specific changes in P.
carinii viability using real time PCR for P. carinii rRNA
copy number. Using this system, we were able to evaluate
multiple experimental manipulations to macrophage func-
tions and determine their effects on killing of P. carinii. Us-
ing an optimal macrophage to P. carinii cyst ratio of 100:1,
we consistently observed a 50% reduction in P. carinii via-
bility using both peritoneal and alveolar macrophages. A
limitation to the real time PCR method of detection we
used in this study is that it does not distinguish between the
cyst and trophozoite forms of P. carinii. Although the mac-
rophage to P. carinii cyst ratios in the viability assay were
based on a known amount of P. carinii cysts, we estimate
that our P. carinii preparations contain 75–100-fold higher
numbers of trophozoites, therefore the ratio of macrophage
to total P. carinii organisms is likely to be significantly lower
(i.e., 1:1) than that represented in the figures.
We attributed the killing of P. carinii by alveolar macro-
phages to be a product of phagocytosis because inhibition
of actin filament polymerization by cytochalasin D treat-
ment rendered the macrophage completely unable to kill
P. carinii. Furthermore, cocultures performed in the pres-
ence of catalase, which converts hydrogen peroxide to wa-
ter and molecular oxygen, had significantly more detect-
able  P. carinii rRNA, and thus more viable organisms,
compared with those performed in the absence of catalase.
These results implicate hydrogen peroxide in the direct
killing of P. carinii by alveolar macrophages. In support of
this, we detected less P. carinii rRNA from organisms that
were cultured in the presence of physiologic concentrations
of hydrogen peroxide. Interestingly, we were unable to de-
tect a role for superoxide as dismutation with a cell-perme-
able superoxide dismutase mimetic did not induce a con-
comitant reduction in alveolar macrophage–mediated
killing of P. carinii. However, it has been hypothesized that
P. carinii may synthesize its own superoxide dismutase (14),
thereby potentially rendering it somewhat resistant to su-
peroxide-mediated damage. This may suggest that super-
oxide-mediated killing plays a minor role in alveolar mac-
rophage defense against P. carinii. Nevertheless, previous
studies have reported a role for both reactive oxygen spe-
cies in the killing of P. carinii. Some reports have shown
that both hydrogen peroxide and superoxide are directly
toxic to P. carinii (12–14). Furthermore, studies have
shown that P. carinii can elicit an oxidative burst of both
hydrogen peroxide and superoxide from macrophages (12,
13). However, our study is the first to specifically inhibit
the induction or activity of hydrogen peroxide, generated
by the interaction between alveolar macrophages and P.
carinii, and demonstrate a specific effect on killing of the or-
ganism. Although the reduction in killing in the presence
of catalase was statistically significant, the observed decrease
was modest. Therefore, we cannot exclude the possibility
that additional intracellular molecules, such as proteases, are
also playing a role in the killing of P. carinii (37).
The primary focus of this study was to evaluate the role
of putative molecular recognition receptors in alveolar
macrophage–mediated killing of P. carinii. For this, we
performed competitive carbohydrate inhibition studies
whereby alveolar macrophages were pretreated with yeast-
derived mannan to block the macrophage MR and there-
after cocultured with P. carinii. In contrast to previous
publications with nonautologous P. carinii/macrophage
systems that investigated the binding and phagocytosis of
P. carinii but not the killing, we observed no reduction in
alveolar macrophage–mediated killing of P. carinii in the
presence of MR blockage. The MR was previously identi-
fied as the first molecular recognition receptor mediating
the binding and uptake of P. carinii (24). Additional studies
have shown that the glycoprotein A of P. carinii specifically
binds to the MR (8). Finally, defects in MR expression
and function have been reported in HIV  individuals with
and without P. carinii infection (7, 15). Although these
studies report the importance of the MR in the recogni-
tion of P. carinii, our results indicate that the killing of P.
carinii by alveolar macrophages may occur independently
of MR recognition. Because we used a syngeneic cocul-
ture of murine P. carinii and murine alveolar macrophages
in our experimental design, differences in our results with
others may potentially be explained through the use of
nonsyngeneic cocultures (i.e., rat-derived P. carinii cocul-
tured with human macrophages) in the previous analyses
(7, 15). Although it has been reported that all P. carinii, re-
gardless of their host of origin, express mannose-contain-
ing surface glycoproteins (38), taking into account the spe-
cies specificity of P. carinii isolates (16, 34), it is
conceivable that the carbohydrate composition of the P.
carinii cell wall might be different between isolates from
different species. Finally, MR-deficient mice were re-
cently shown to have no defects in phagocytosis and no
overt susceptibility to C. albicans (39), a fungal organism
containing a mannose-enriched cell wall that is recognized
by the MR (40). However, phagocytosis of C. albicans was
inhibited by  -glucan, suggesting alternative receptors re-
sponsible for phagocytosis of this organism. To specifically
address the role of the macrophage MR, we isolated alve-
olar macrophages from MR-deficient (MR / ) mice (22)
and cocultured them with fluorescently labeled P. carinii in
an in vitro phagocytosis assay. We observed no defects in
the ability of alveolar macrophages from MR /  mice to
internalize both P. carinii cysts and trophozoites compared
with alveolar macrophages from wild-type control mice.
Furthermore, Swain et al. (41) have recently reported that
MR /  mice clear P. carinii from the lungs similar to wild-
type control mice. Taken together, these data suggest that
the macrophage MR is not required for the binding and
killing of murine P. carinii.
Our studies support a role for other receptors mediating
the killing of P. carinii by alveolar macrophages, namely
 -glucan receptors. Analysis of the P. carinii cell wall has
shown that  -glucans constitute the majority of carbohy-
drate moieties (42, 43). As well, studies have shown a dis-Macrophage Killing of Pneumocystis carinii 1686
tinct role for  -glucan receptors in the alveolar macro-
phage inflammatory response (10, 11). Recently, the major
 -glucan receptor on macrophages was identified as Dec-
tin-1 (20, 21). Dectin-1 is a 28-kD, type II transmembrane
receptor containing one lectin-like carbohydrate recogni-
tion domain, which recognizes  1,3-linked and  1,6-
linked glucans and intact fungal organisms. Therefore, we
performed studies to address the role of  -glucan receptors
in alveolar macrophage–mediated killing of P. carinii. Initial
competitive carbohydrate inhibition studies showed poor
killing of P. carinii by alveolar macrophages in the presence
of S. cerevisiae–derived glucan, suggesting that a  -glucan
receptor was critical in nonopsonic killing of P. carinii. Sub-
sequent studies using immunofluorescent microscopy
showed high levels of Dectin-1  -glucan receptor expres-
sion on alveolar macrophages. Preincubation of alveolar
macrophages with an anti–Dectin-1 monoclonal antibody
significantly abrogated the killing of P. carinii. We con-
firmed the interaction of Dectin-1 on alveolar macrophages
and P. carinii by using fluorescent deconvolution micros-
copy that showed alveolar macrophages binding P. carinii in
the presence of low concentrations of anti–Dectin-1 anti-
body but not in the presence of 20-fold higher concentra-
tions. We were also able to demonstrate colocalization of
Dectin-1 interacting with the P. carinii cell wall. Additional
studies showed that RAW 264.7 macrophages overexpress-
ing Dectin-1 bound P. carinii at higher levels than control
macrophages and the binding was significantly inhibited
when Dectin-1 was blocked. Finally, confirming the im-
portance of Dectin-1 in recognition and internalization of
P. carinii, alveolar macrophages from MR /  mice pre-
treated with anti–Dectin-1 antibody have significant reduc-
tions in P. carinii internalization. Taken together, our re-
sults support the discovery of the Dectin-1  -glucan
receptor as a critical receptor responsible for the nonop-
sonic recognition and subsequent inhibitory function by al-
veolar macrophages against P. carinii.
In addition, we report here that elicitation of the proin-
flammatory chemokine MIP-2 from alveolar macrophages
by whole P. carinii organisms is also dependent on Dectin-1
as a  75% reduction in MIP-2 production was observed
from alveolar macrophages pretreated with anti–Dectin-1
monoclonal antibody and exposed to P. carinii. Moreover,
RAW 264.7 macrophages overexpressing Dectin-1 pro-
duced more MIP-2 than control macrophages when cocul-
tured with P. carinii and the elicitation of MIP-2 was com-
pletely abrogated when these cells were pretreated with
anti–Dectin-1 antibody. Dectin-1 was initially reported to
contain an immunoreceptor tyrosine-based activation motif
in the cytoplasmic tail (44). A recent study reported pro-
duction of TNF-  in response to zymosan, C. albicans, and
S. cerevisiae by the RAW macrophage cell line that overex-
pressed Dectin-1 (26). Furthermore, zymosan-induced
TNF-  production was significantly blunted in RAW cells
transfected with truncated Dectin-1 or with Dectin-1 con-
taining a mutated immunoreceptor tyrosine-based activa-
tion motif (26). Although alveolar macrophages have been
shown to produce both TNF-  and MIP-2 in response to
purified P. carinii cell wall  -glucans, we were unable to
elicit significant levels of TNF-  using whole P. carinii or-
ganisms (unpublished data). Nevertheless, we show that al-
veolar macrophage–mediated proinflammatory chemokine
responses to P. carinii requires Dectin-1.
We also examined alveolar macrophage–mediated killing
of  P. carinii through opsonic pathways and determined
whether Dectin-1 was required. Opsonized P. carinii could
be killed by alveolar macrophages either through Dectin-
1–mediated phagocytosis or Fc RII/III-mediated phago-
cytosis. However, upon blockage of both Dectin-1 and
Fc RII/III, alveolar macrophages were completely unable
to kill opsonized P. carinii.
In conclusion, our data indicates that nonopsonic mac-
rophage-mediated killing of P. carinii is specifically depen-
dent on recognition of P. carinii by the Dectin-1  -glucan
receptor leading to phagocytosis and subsequent killing of
the organism by hydrogen peroxide. Furthermore, we re-
port that the Dectin-1  -glucan receptor is required for ef-
ficient elicitation of proinflammatory chemokines, such as
MIP-2, by alveolar macrophages in response to P. carinii.
 1,3-linked and  1,6-linked glucan moieties are prevalent
in the cell walls of such medically important fungi as As-
pergillus fumigatus and C. albicans (45). Further investiga-
tions into the role of Dectin-1 in these fungal diseases will
provide invaluable insight as to how these organisms are
recognized by the innate immune system. Finally, although
it is not currently known whether HIV infection affects
Dectin-1 expression, our results support the importance of
developing antibody-based vaccination strategies (18) for
P. carinii as anti–P. carinii IgG not only significantly en-
hanced alveolar macrophage host defense against P. carinii,
but also restored macrophage phagocytosis in the presence
of Dectin-1 blockage.
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